+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Human Microbiome Sequencing Services Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6138548
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Microbiome Sequencing Services Market is projected to reach USD 4.38 Billion in 2026. It is expected to continue growing at a CAGR of 12.56%, reaching USD 8.89 Billion by 2032.

Human Microbiome Sequencing Services: Executive Overview

Human microbiome sequencing services support the identification and characterization of microorganisms associated with human health and disease. The field combines sample collection, nucleic-acid extraction, sequencing, bioinformatics, and interpretation across research, clinical, pharmaceutical, nutrition, and public-health applications. Its development is shaped by improvements in sequencing accuracy, analytical workflows, specimen handling, and the standardization of microbiome data.

Standardization and Multi-Omic Integration Are Reshaping the Field

The landscape is shifting from isolated taxonomic profiling toward integrated analysis of microbial composition, function, host biology, and environmental context. Long-read sequencing, improved metagenomic workflows, strain-level resolution, and more consistent reference databases are helping researchers address limitations associated with short reads and incomplete annotation. At the same time, study quality increasingly depends on standardized collection protocols, contamination controls, metadata capture, and reproducible bioinformatics pipelines.

Artificial Intelligence Expands Interpretation While Increasing Governance Needs

Artificial intelligence is being applied to taxonomic classification, biomarker discovery, functional prediction, quality control, and the integration of microbiome data with clinical and genomic information. Machine-learning systems can help identify complex associations that are difficult to detect through conventional analyses, but their value depends on representative training data, transparent validation, and careful separation of correlation from causation. Privacy protection, explainability, external validation, and controls against batch effects remain essential when AI-supported findings inform clinical or translational decisions.

Regional Insights: Different Infrastructure and Regulatory Conditions Shape Adoption

North America benefits from extensive biomedical research capacity, established sequencing infrastructure, and strong activity in translational medicine, while Latin America is advancing through academic networks and public-health research but continues to face uneven access to specialized platforms and sample logistics. Europe emphasizes data governance, harmonized research practices, and cross-border collaboration, with the European Union supporting coordinated scientific frameworks. The Middle East is developing genomics and precision-health capabilities, although expertise and infrastructure vary across countries. Africa has important opportunities in population diversity and infectious-disease research, alongside persistent constraints in funding, laboratory capacity, and data representation. Asia-Pacific combines advanced capabilities in countries such as Japan, South Korea, Australia, and China with rapidly developing research ecosystems elsewhere, creating broad but uneven adoption conditions.

Group Insights: Collaboration Networks Influence Research Capability

ASEAN countries are strengthening regional research links, but differences in laboratory infrastructure, regulatory systems, and bioinformatics capacity affect project execution. BRICS members bring substantial population diversity and research potential, while collaboration is influenced by varied data policies and investment environments. The European Union prioritizes harmonization, interoperability, and responsible data use across member states. G7 countries generally possess mature research and healthcare infrastructures, supporting complex translational programs. GCC countries are investing in genomics, clinical research, and national health infrastructure, while NATO members provide a broad network of scientific and public-health capabilities with differing national priorities and compliance requirements.

Country Insights: National Strengths Are Uneven Across the Research Chain

Australia combines strong biomedical research and bioinformatics expertise with distinctive population and environmental study opportunities. Brazil and Mexico are expanding microbiome research while addressing regional disparities in laboratory access and sample transport. Canada, the United States, the United Kingdom, France, Germany, Italy, Spain, and Japan benefit from established research institutions, clinical networks, and sequencing capabilities, although their regulatory and reimbursement environments differ. China and South Korea have developed substantial genomics infrastructure and computational capacity, with data governance remaining a central consideration. India offers a large and diverse research base alongside varied access to advanced facilities. Russia retains scientific capabilities but operates within a complex international collaboration environment.

Action Priorities for Leaders: Build Reproducible, Interpretable, and Compliant Workflows

Industry leaders should prioritize end-to-end quality management, including validated collection methods, controls for contamination, documented chain of custody, and reproducible analytical pipelines. Partnerships with clinical, academic, and public-health organizations can improve cohort diversity and external validation. Organizations should also invest in interoperable data standards, secure computing, transparent AI evaluation, and staff skilled in both molecular biology and computational analysis. Clear evidence plans are important: define the intended use, distinguish exploratory from confirmatory findings, and establish requirements for analytical validity, clinical relevance, and regulatory compliance before scaling a service.

Research Methodology: Evidence-Based Assessment of Service Capabilities

The assessment uses a structured review of publicly available scientific literature, peer-reviewed studies, regulatory and policy materials, institutional information, technical documentation, and evidence on sequencing and bioinformatics practices. Findings are organized by technology, application, geography, economic group, and country, with attention to infrastructure, data governance, workforce, sample logistics, and translational readiness. Qualitative synthesis emphasizes verifiable developments and avoids unsupported numerical claims; where evidence is heterogeneous, conclusions are framed as directional rather than definitive.

Conclusion: Scientific Utility Depends on Quality, Context, and Responsible Translation

Human microbiome sequencing services are becoming more useful as sequencing platforms, analytical methods, and biological reference resources improve. The strongest opportunities are associated with well-designed studies that connect microbial observations to host outcomes and reproducible functional evidence. Progress will depend less on sequencing alone than on standardized sampling, diverse datasets, robust interpretation, responsible AI, secure data practices, and collaboration across research and healthcare systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human Microbiome Sequencing Services Market, by Service Type
7.1. Introduction
7.2. 16S Rrna Sequencing
7.2.1. Illumina Sequencing
7.2.2. Oxford Nanopore Sequencing
7.2.3. Pacbio Sequencing
7.3. Metatranscriptomic Sequencing
7.3.1. Illumina Sequencing
7.3.2. Oxford Nanopore Sequencing
7.3.3. Pacbio Sequencing
7.4. Shotgun Metagenomic Sequencing
7.4.1. Illumina Sequencing
7.4.2. Oxford Nanopore Sequencing
7.4.3. Pacbio Sequencing
8. Human Microbiome Sequencing Services Market, by Sample Type
8.1. Introduction
8.2. Gut Microbiome
8.3. Oral Microbiome
8.4. Skin Microbiome
8.5. Vaginal Microbiome
9. Human Microbiome Sequencing Services Market, by Application
9.1. Introduction
9.2. Agricultural And Animal Health
9.3. Diagnostics
9.4. Microbiome Research
9.5. Personalized Medicine
9.6. Therapeutics Development
10. Human Microbiome Sequencing Services Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Clinical Laboratories And Hospitals
10.4. Contract Research Organizations
10.5. Pharmaceutical And Biotechnology Companies
11. Human Microbiome Sequencing Services Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Human Microbiome Sequencing Services Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Human Microbiome Sequencing Services Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. BaseClear B.V.
15.2. Boster Biological Technology Ltd.
15.3. CD Genomics
15.4. Charles River Laboratories International, Inc.
15.5. Clinical Microbiomics A/S
15.6. Clinical-Microbiomics
15.7. CosmosID, Inc.
15.8. Diversigen, Inc.
15.9. Eurofins Scientific LLC
15.10. Illumina, Inc.
15.11. Macrogen Inc.
15.12. Merieux Nutrisciences Corporation
15.13. Microba Life Sciences Limited
15.14. Microbiome Insights Inc.
15.15. Molzym GmbH & Co. KG
15.16. MR DNA
15.17. Novogene Co., Ltd.
15.18. Psomagen Inc.
15.19. QIAGEN N.V.
15.20. Rancho Biosciences LLC
15.21. Second Genome, Inc.
15.22. Shanghai Realbio Technology Co., Ltd.
15.23. Thermo Fisher Scientific Inc.
15.24. Zifo RnD Solutions
15.25. Zymo Research Corporation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human Microbiome Sequencing Services Market, Years Considered for the Study
FIGURE 2. Global Human Microbiome Sequencing Services Market, Research Design
FIGURE 3. Global Human Microbiome Sequencing Services Market, Research Framework
FIGURE 4. Global Human Microbiome Sequencing Services Market, Data Triangulation
FIGURE 5. Global Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human Microbiome Sequencing Services Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global Human Microbiome Sequencing Services Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human Microbiome Sequencing Services Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 9. Global Human Microbiome Sequencing Services Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human Microbiome Sequencing Services Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Human Microbiome Sequencing Services Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human Microbiome Sequencing Services Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Human Microbiome Sequencing Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human Microbiome Sequencing Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Human Microbiome Sequencing Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Human Microbiome Sequencing Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Human Microbiome Sequencing Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Human Microbiome Sequencing Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Human Microbiome Sequencing Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human Microbiome Sequencing Services Market Segmentation & Coverage
TABLE 2. Global Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global 16S Rrna Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global 16S Rrna Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global 16S Rrna Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Illumina Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Illumina Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Illumina Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Oxford Nanopore Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Oxford Nanopore Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Oxford Nanopore Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pacbio Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pacbio Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pacbio Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Metatranscriptomic Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Metatranscriptomic Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Metatranscriptomic Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Illumina Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Illumina Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Illumina Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Oxford Nanopore Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Oxford Nanopore Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Oxford Nanopore Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Pacbio Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Pacbio Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Pacbio Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Shotgun Metagenomic Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Shotgun Metagenomic Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Shotgun Metagenomic Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Illumina Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Illumina Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Illumina Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Oxford Nanopore Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Oxford Nanopore Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Oxford Nanopore Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Pacbio Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Pacbio Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Pacbio Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 41. Global Gut Microbiome Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Gut Microbiome Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Gut Microbiome Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Oral Microbiome Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Oral Microbiome Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Oral Microbiome Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Skin Microbiome Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Skin Microbiome Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Skin Microbiome Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Vaginal Microbiome Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Vaginal Microbiome Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Vaginal Microbiome Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 54. Global Agricultural And Animal Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Agricultural And Animal Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Agricultural And Animal Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Microbiome Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Microbiome Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Microbiome Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Therapeutics Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Therapeutics Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Therapeutics Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 70. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Clinical Laboratories And Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Clinical Laboratories And Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Clinical Laboratories And Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Pharmaceutical And Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Pharmaceutical And Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Pharmaceutical And Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Human Microbiome Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Human Microbiome Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. North America Human Microbiome Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. North America Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 93. North America Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 94. North America Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 95. North America Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 96. North America Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 97. North America Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. North America Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Latin America Human Microbiome Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Latin America Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 101. Latin America Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 102. Latin America Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 103. Latin America Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 104. Latin America Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 105. Latin America Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. Latin America Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Europe Human Microbiome Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Europe Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 109. Europe Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 110. Europe Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 111. Europe Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 112. Europe Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 113. Europe Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. Europe Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Middle East Human Microbiome Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Middle East Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 117. Middle East Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 118. Middle East Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 119. Middle East Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 120. Middle East Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 121. Middle East Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Middle East Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Africa Human Microbiome Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Africa Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 125. Africa Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 126. Africa Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 127. Africa Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 128. Africa Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 129. Africa Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. Africa Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Global Human Microbiome Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. ASEAN Human Microbiome Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. ASEAN Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 134. ASEAN Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 135. ASEAN Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 136. ASEAN Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 137. ASEAN Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 138. ASEAN Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. ASEAN Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. GCC Human Microbiome Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. GCC Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 142. GCC Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 143. GCC Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 144. GCC Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 145. GCC Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 146. GCC Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. GCC Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. European Union Human Microbiome Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. European Union Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 150. European Union Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 151. European Union Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 152. European Union Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 153. European Union Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 154. European Union Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. European Union Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. BRICS Human Microbiome Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. BRICS Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 158. BRICS Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 159. BRICS Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 160. BRICS Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 161. BRICS Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 162. BRICS Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. BRICS Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. G7 Human Microbiome Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. G7 Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 166. G7 Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 167. G7 Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 168. G7 Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 169. G7 Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 170. G7 Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. G7 Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. NATO Human Microbiome Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. NATO Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 174. NATO Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 175. NATO Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 176. NATO Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 177. NATO Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 178. NATO Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. NATO Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Global Human Microbiome Sequencing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. United States Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 182. United States Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 183. United States Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 184. United States Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 185. United States Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 186. United States Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 187. United States Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. United States Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Canada Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 190. Canada Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 191. Canada Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 192. Canada Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 193. Canada Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 194. Canada Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 195. Canada Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Canada Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Mexico Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 198. Mexico Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 199. Mexico Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 200. Mexico Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 201. Mexico Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 202. Mexico Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 203. Mexico Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Mexico Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Brazil Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 206. Brazil Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 207. Brazil Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 208. Brazil Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 209. Brazil Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 210. Brazil Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 211. Brazil Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. Brazil Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. United Kingdom Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 214. United Kingdom Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 215. United Kingdom Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 216. United Kingdom Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 217. United Kingdom Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 218. United Kingdom Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 219. United Kingdom Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. United Kingdom Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Germany Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 222. Germany Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 223. Germany Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 224. Germany Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 225. Germany Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 226. Germany Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 227. Germany Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. Germany Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. France Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 230. France Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 231. France Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 232. France Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 233. France Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 234. France Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 235. France Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. France Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Russia Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 238. Russia Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 239. Russia Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 240. Russia Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 241. Russia Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 242. Russia Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 243. Russia Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Russia Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Italy Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 246. Italy Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 247. Italy Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 248. Italy Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 249. Italy Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 250. Italy Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 251. Italy Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. Italy Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Spain Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 254. Spain Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 255. Spain Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 256. Spain Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 257. Spain Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 258. Spain Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 259. Spain Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Spain Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. China Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 262. China Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 263. China Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 264. China Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 265. China Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 266. China Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 267. China Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. China Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. India Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 270. India Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 271. India Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 272. India Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 273. India Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 274. India Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 275. India Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 276. India Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Japan Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 278. Japan Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 279. Japan Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 280. Japan Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 281. Japan Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 282. Japan Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 283. Japan Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. Japan Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Australia Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 286. Australia Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 287. Australia Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 288. Australia Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 289. Australia Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 290. Australia Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 291. Australia Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 292. Australia Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. South Korea Human Microbiome Sequencing Services Market Size, 2017-2032 (USD Million)
TABLE 294. South Korea Human Microbiome Sequencing Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 295. South Korea Human Microbiome Sequencing Services Market Size, by 16S Rrna Sequencing, 2017-2032 (USD Million)
TABLE 296. South Korea Human Microbiome Sequencing Services Market Size, by Metatranscriptomic Sequencing, 2017-2032 (USD Million)
TABLE 297. South Korea Human Microbiome Sequencing Services Market Size, by Shotgun Metagenomic Sequencing, 2017-2032 (USD Million)
TABLE 298. South Korea Human Microbiome Sequencing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 299. South Korea Human Microbiome Sequencing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. South Korea Human Microbiome Sequencing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Global Human Microbiome Sequencing Services Market Share, by Key Player, 2025
TABLE 302. Global Human Microbiome Sequencing Services Market, Key Experts

Companies Mentioned

  • BaseClear B.V.
  • Boster Biological Technology Ltd.
  • CD Genomics
  • Charles River Laboratories International, Inc.
  • Clinical Microbiomics A/S
  • Clinical‑Microbiomics
  • CosmosID, Inc.
  • Diversigen, Inc.
  • Eurofins Scientific LLC
  • Illumina, Inc.
  • Macrogen Inc.
  • Merieux Nutrisciences Corporation
  • Microba Life Sciences Limited
  • Microbiome Insights Inc.
  • Molzym GmbH & Co. KG
  • MR DNA
  • Novogene Co., Ltd.
  • Psomagen Inc.
  • QIAGEN N.V.
  • Rancho Biosciences LLC
  • Second Genome, Inc.
  • Shanghai Realbio Technology Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Zifo RnD Solutions
  • Zymo Research Corporation